Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Alcon patent covers new 5-HT2 agonists for glaucoma therapy

Aug. 5, 2004

No Comments

ISTA launches Istalol for glaucoma

Aug. 2, 2004

No Comments

FDA accepts for review Xibrom NDA

July 28, 2004

No Comments

AzaSite enters two phase III studies for acute bacterial conjunctivitis

July 26, 2004

No Comments

Completion of financing round at Acuity

July 21, 2004

No Comments

Merck & Co. and Alnylam collaborate on RNAi therapeutics for ocular diseases

July 6, 2004

No Comments

Alcon files second portion of Retaane rolling NDA

July 6, 2004

No Comments

Isis earns milestone for Macugen NDA filing

July 1, 2004

No Comments

Statins a potential therapeutic option in glaucoma

June 29, 2004

No Comments

Istalol NDA for glaucoma approved

June 9, 2004

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Ocular
RSS

Alcon patent covers new 5-HT2 agonists for glaucoma therapy

ISTA launches Istalol for glaucoma

FDA accepts for review Xibrom NDA

AzaSite enters two phase III studies for acute bacterial conjunctivitis

Completion of financing round at Acuity

Merck & Co. and Alnylam collaborate on RNAi therapeutics for ocular diseases

Alcon files second portion of Retaane rolling NDA

Isis earns milestone for Macugen NDA filing

Statins a potential therapeutic option in glaucoma

Istalol NDA for glaucoma approved

Today's news in brief

Today's news in brief

STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space

GLP-1 receptor agonists continue their global victory tour

AI drives financings, approvals for APAC med-tech in 2024

Ocular RSS

Ocular
RSS